ILC2s participate in immune surveillance against CTCs, since in transplantable murine models they are recruited to the primary tumor in an IL-33-reliant manner and mediate CTL activation together with DCs, hence producing a decrease in tumor growth, CTCs (evaluated by FACS), and metastasis [56]. This evidence concerns the gene IL33 and neoplasm.